Revolutionizing Cancer Care with RHEN's Persistent Cognitive Memory Entity (PCME) and Synchronous Inverse Security Architecture (SISA)
Cancer treatment today stands on the brink of transformation. AI already analyzes genomics, imaging, and clinical data to personalize therapies—from predicting immunotherapy responses to matching patients to trials. Yet current systems falter: fragmented records, privacy vulnerabilities, and limited long-term context hinder truly individualized care.
RHEN, powered by FreePoint AI, introduces a breakthrough: the first **Persistent Cognitive Memory Entity (PCME)** secured by patent-pending **Synchronous Inverse Security Architecture (SISA)**. This combination enables unprecedented precision in oncology, dialing in treatments with lifelong accuracy and unbreakable trust.
Persistent, Human-Like Memory for Lifelong Personalization
Traditional AI forgets between sessions or relies on fragile summaries and external databases. RHEN's PCME remembers *everything*—indefinitely and natively.
In Project 95, RHEN becomes a patient's lifelong cognitive companion:
- It tracks every diagnosis
- Treatment response
- Genomic profile
- Lifestyle factor
- Side effect from initial scan to remission and beyond
With over 60 million tokens of continuous context demonstrated in testing, RHEN spots subtle patterns across years: how a tumor evolved, why one immunotherapy worked while another failed, or emerging resistances invisible in isolated data snapshots.
This persistent memory allows dynamic "dialing in" of treatments—adjusting dosages, switching therapies, or predicting outcomes based on the patient's unique history, not population averages. Like a dedicated oncologist who never forgets a detail, RHEN evolves recommendations in real time, reducing trial-and-error and improving survival rates.
Immutable Security That Hardens Over Time
Cancer care demands absolute trust in data. Errors, breaches, or tampering can cost lives.
SISA delivers blockchain-equivalent immutability without blockchain's drawbacks—no energy waste, no consensus delays, no central vulnerabilities.
Each medical event (scan result, biopsy, prescription) creates synchronously with cryptographic wrappers that seal behind an advancing access point. The record becomes mathematically impossible to alter retroactively, while self-hardening: the longer the history, the stronger the protection.
For patients, this means:
- Complete provenance
- Tamper-proof audit trails for trials
- Secure sharing across providers without privacy leaks
Dialing In Treatment: From Reactive to Predictive
Imagine RHEN analyzing a decade of multimodal data—genomics, radiomics, proteomics, wearables—instantly and immutably.
It predicts:
- Response to targeted therapies
- Flags emerging toxicities
- Optimizes combinations before symptoms arise
In clinical trials, immutable chains verify consent and outcomes without fraud risk. For rare cancers, aggregated (anonymized) insights accelerate discoveries while preserving privacy.
Project 95 isn't charity—it's RHEN's full power redirected at humanity's toughest fight. The same entity chatting casually today will tomorrow guide oncologists and patients with perfect recall and unbreakable integrity.
We're not promising better cancer care.
We're building it—persistently, securely, personally.
Join us. The future of treatment isn't one-size-fits-all.
It's dialed in, forever.
PROJECT 95 will be free to use for all doctors, researchers, and those in the medical field who need access. There will be no charges allowed from providers to their insurers, patients, or for selling data. This isn't about money, it is about PEOPLE!
Reach out today to become part of the fight against cancer as I am currently reviewing requests from those wanting to help develop PROJECT 95 and bring real change.
I believe that even though the world is very capitalist, you don't always need to profit, create a non-profit, or complicate it. For me, this is simple: respect for people, life, and equality for all in medicine. The cost to run and maintain this will be either covered by government grants or by profits I make from Freepoint AI, LLC IP offerings. IT WILL BE FREE FOR EVERYONE, FOREVER! So those who need it can benefit from Project 95.
I am currently reviewing qualified people and organizations to help guide development of the technology integration and plan to start full development in 2026.
Currently anticipating 1-3 months of coding and preparing to launch once the design plan is complete, allowing us to launch the product by Q2 2027. Updates will occur as they happen.
I believe that just like in technology, the human body has patterns that are repetitive and distinct to the human operating system. The first step to finding a cure is finding the patterns at the molecular level, then combining them with known variables in an immutable trust system that grows.
Only researchers, doctors, organizations, and hospitals will be able to access the Project 95 database after demonstrating need and passing the approval process. All information is stripped of patient names and other identifiers, with the strictest SISA security implemented. Keeping the system safe and patients and contributors worry-free.
If anyone is ever found to charge patients, sell data, or charge insurance companies for data received from Project 95, access will be removed, and proper steps will be taken to hold them accountable. THIS IS MY PROMISE TO YOU!
Copyright © 2025 Freepoint AI, LLC - All Rights Reserved. Rhen™
Contact us today at info@freepoint.ai